Desperately seeking serotonin… A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders

PJ Pasricha - Gastroenterology, 2007 - gastrojournal.org
In March 2007, Novartis suspended marketing of tega-serod maleate (Zelnorm), an agonist
for the 5-HT4 serotonin receptor used for patients with irritable bowel syndrome (IBS) and …
被引用次数：118 相关文章

[引用][C] Desperately Seeking Serotonin… A Commentary on the Withdrawal of Tegaserod and the State of Drug Development for Functional and Motility Disorders

PJ Pasricha - Gastroenterology, 2007 - infona.pl
Desperately Seeking Serotonin… A Commentary on the Withdrawal of Tegaserod and the
State of Drug Development for Functional and Motility Disorders × Close The Infona portal …

[引用][C] Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.

PJ Pasricha - Gastroenterology, 2007 - europepmc.org
Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the
state of drug development for functional and motility disorders. - Abstract - Europe PMC …

[引用][C] Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders

PJ Pasricha - Gastroenterology, 2007 - pubmed.ncbi.nlm.nih.gov
Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the
state of drug development for functional and motility disorders Desperately seeking …

[引用][C] Desperately Seeking Serotonin... A Commentary on the Withdrawal of Tegaserod and the State of Drug Development for Functional and Motility Disorders

PJ Pasricha - Gastroenterology, 2007 - pure.johnshopkins.edu
Desperately Seeking Serotonin... A Commentary on the Withdrawal of Tegaserod and the
State of Drug Development for Functional and Motility Disorders — Johns Hopkins …

[引用][C] Desperately Seeking Serotonin… A Commentary on the Withdrawal of Tegaserod and the State of Drug Development for Functional and Motility Disorders

PJ Pasricha - Gastroenterology, 2007 - WB Saunders